Cambridge Innovation Capital

Investor type

VC

Founded

2013

AUM

-

Location

Cambridge, England, United Kingdom

Investment Ticket

-

Investment Stage

Seed Series A

Region of investment

North America Europe
Investor profile last updated: 16 August, 2026

Profile

Cambridge Innovation Capital is a venture capital firm based in Cambridge, United Kingdom, founded in 2013. The firm focuses on investing in life sciences and deep technology sectors, leveraging its structured access to Cambridge's intellectual property and academic resources. The team comprises 10 professionals who bring a wealth of experience in venture capital and technology investments.

The firm invests in sectors such as artificial intelligence, quantum technologies, semiconductors, robotics, autonomous systems, therapeutics, medtech, diagnostics, digital health, and genomics & proteomics. Cambridge Innovation Capital typically invests in Seed and Series A stages, focusing on companies across the United Kingdom. The firm is actively seeking new investments and is a member of the British Venture Capital Association and Principles for Responsible Investment.

Notable investments include TRIMTECH Therapeutics - drug discovery, Trent AI - network management software, Immutrin - drug discovery, BeyondMath - business/productivity software, and Nuclera - healthcare technology systems. The firm has a portfolio of 27 companies and has achieved 20 exits.

Industry

Biotechnology Robotics AI MedTech Life Sciences HealthTech Deeptech Semiconductors / Chips

Contacts

Name
Title
Email
avatar
Andrew Williamson Managing Partner
Managing Partner
a•••@•••
avatar
Rob Sprawson Partner and CFO
Partner and CFO
r•••@•••
Upgrade to see contacts
avatar
2BjZ54Pzmk9XnEDa 2BjZ54Pzmk9XnEDa
2BjZ54Pzmk9XnEDa
avatar
2BjZ54Pzmk9XnEDa 2BjZ54Pzmk9XnEDa
2BjZ54Pzmk9XnEDa
avatar
2BjZ54Pzmk9XnEDa 2BjZ54Pzmk9XnEDa
2BjZ54Pzmk9XnEDa
Investment-team contacts for Cambridge Innovation Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Cambridge Innovation Capital

Cambridge Innovation Capital is a venture capital firm. It backs companies at Seed and Series A.
Cambridge Innovation Capital is located in Cambridge, England, United Kingdom.
Cambridge Innovation Capital was founded in 2013.
Cambridge Innovation Capital invests in companies and startups in Biotechnology, Robotics, AI, MedTech, Life Sciences, HealthTech, Deeptech, Semiconductors / Chips.
Cambridge Innovation Capital invests in companies and startups in North America, Europe.
Cambridge Innovation Capital invests in companies and startups at Seed, Series A.
Cambridge Innovation Capital can be reached through its website cic.vc, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Cambridge Innovation Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Cambridge Innovation Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.